Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z Best Place to Talk Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Larry S. who wrote (19599)	3/17/1999 2:24:00 PM
From: DanZ	Read Replies (1) \| Respond to of 53068

GUMM. To those who are following GUMM, you might be interested in news from Watson Pharmaceuticals today that says they received approval for an ANDA from the FDA to make a nicotine cessation gum. Watson's gum will compete with Smith Kline Beechum's Nicorette gum. www1.newsalert.com Rumors have been circulating that Gumtech will manufacture the gum for Watson. While I can't confirm it at this time, I believe this rumor to be true. If it is, it would be very positive for Gumtech as the size of the smoking cessation market is very large and Watson would distribute the product in the US and internationally. GUMM has been well bid today and has positive money flow. It looks as if the market expects GUMM to make this product for Watson. I'll pass on more specifics as I get them. Dan